Squarepoint
ADPT icon

Squarepoint’s Adaptive Biotechnologies ADPT Stock Holding History

Squarepoint’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69M Buy
121,986
+52,251
+75% +$832K ﹤0.01% 2321
2025
Q4 		$1.13M Sell
69,735
-121,374
-64% -$1.98M ﹤0.01% 2498
2025
Q3 		$2.86M Sell
191,109
-26,842
-12% -$327K ﹤0.01% 1823
2025
Q2 		$2.54M Buy
217,951
+150,963
+225% +$1.37M ﹤0.01% 1918
2025
Q1 		$498K Buy
66,988
+22,587
+51% +$174K ﹤0.01% 3306
2024
Q4 		$266K Buy
44,401
+32,247
+265% +$178K ﹤0.01% 4244
2024
Q3 		$62.2K Buy
+12,154
New +$53K ﹤0.01% 3956
2024
Q1 		– Sell
-75,659
Closed -$371K – 3949
2023
Q4 		$371K Buy
+75,659
New +$345K ﹤0.01% 3220
2023
Q3 		– Sell
-31,637
Closed -$212K – 3731
2023
Q2 		$212K Buy
+31,637
New +$235K ﹤0.01% 3189
2023
Q1 		– Sell
-50,889
Closed -$389K – 3171
2022
Q4 		$389K Sell
50,889
-92,118
-64% -$717K ﹤0.01% 2432
2022
Q3 		$1.02M Buy
+143,007
New +$1.35M 0.01% 1761
2022
Q2 		– Sell
-57,432
Closed -$797K – 2829
2022
Q1 		$797K Buy
+57,432
New +$903K ﹤0.01% 1720
2021
Q2 		– Sell
-41,956
Closed -$1.69M – 3173
2021
Q1 		$1.69M Buy
+41,956
New +$2.27M 0.01% 1162
2019
Q4 		– Sell
-10,910
Closed -$337K – 2448
2019
Q3 		$337K Buy
+10,910
New +$445K ﹤0.01% 1838

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Squarepoint's ADPT Position: Q1 2026 in Review

Squarepoint increased its Adaptive Biotechnologies (ADPT) stake by 75% in Q1 2026, buying an estimated $832K and bringing the position to 121,986 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2321.

Squarepoint first reported a position in ADPT in Q3 2019 and has held it in 14 quarters since. The position peaked at $2.86M in Q3 2025. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Squarepoint held 121,986 shares of Adaptive Biotechnologies worth $1.69M as of Q1 2026.
  • Squarepoint bought 52,251 Adaptive Biotechnologies shares in Q1 2026, an estimated $832K.
  • Adaptive Biotechnologies made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2321 holding.
  • Squarepoint first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 14 quarters since.
  • Squarepoint's Adaptive Biotechnologies position peaked at $2.86M in Q3 2025.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.